Lack of paradoxical bronchoconstriction after administration of tiotropium via Respimat(®) Soft Mist™ Inhaler in COPD

Bronchoconstriction has been reported in asthma and chronic obstructive pulmonary disease (COPD) patients after administration of some aqueous inhalation solutions. We investigated the incidence of this event during long-term clinical trials of tiotropium delivered via Respimat(®) Soft Mist™ Inhaler...

Descripción completa

Detalles Bibliográficos
Autores principales: Hodder, Rick, Pavia, Demetri, Lee, Angela, Bateman, Eric
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2011
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3144844/
https://www.ncbi.nlm.nih.gov/pubmed/21814460
http://dx.doi.org/10.2147/COPD.S16094

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3144844/
https://www.ncbi.nlm.nih.gov/pubmed/21814460
http://dx.doi.org/10.2147/COPD.S16094

Ejemplares similares